Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multipoint microbiological assay for detecting beta-lactamase.

K J Thickett1, T G Winstanley

  • 1Department of Bacteriology, Royal Hallamshire Hospital, Sheffield.

Journal of Clinical Pathology
|May 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EUCAST expert rules in antimicrobial susceptibility testing.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2011
Same author

Differentiation of vancomycin-resistant enterococci using enterococcus differential medium.

British journal of biomedical science·2005
Same author

Phenotypic detection of beta-lactamase-mediated resistance to oxyimino-cephalosporins in Enterobacteriaceae: evaluation of the Mastascan Elite Expert System.

The Journal of antimicrobial chemotherapy·2005
Same author

First isolation of a CTX-M-3 beta-lactamase producer in the United Kingdom.

International journal of antimicrobial agents·2004
Same author

Evaluation of the mastascanelite image analysis system for measuring zones of inhibition in disc diffusion susceptibility tests.

British journal of biomedical science·2003
Same author

Screening for urinary tract infection with the Mastascan Elite.

British journal of biomedical science·2003
Same journal

Defining biochemical, pathological and molecular factors prognostic in terms of disease control and survival in high-grade extremity soft tissue sarcoma: a scoping review.

Journal of clinical pathology·2026
Same journal

MILGDF: a multi-task, instance-level supervised model for oral squamous cell carcinoma integrating local-global attention and dynamic decision fusion.

Journal of clinical pathology·2026
Same journal

Paediatric B-lymphoblastic leukaemia with low peripheral blasts: a potential diagnostic pitfall.

Journal of clinical pathology·2026
Same journal

MRI-targeted versus systematic needle core biopsies in prostate cancer: a patient-based analysis of potential diagnostic and biologic underestimation.

Journal of clinical pathology·2026
Same journal

Basal plasmacytosis and eosinophilia for distinguishing inflammatory bowel disease from gastrointestinal tuberculosis on mucosal biopsy.

Journal of clinical pathology·2026
Same journal

Assay-dependent variability in free thyroxine (FT4): differential interference related to immunoassay design in a patient with subclinical hypothyroidism.

Journal of clinical pathology·2026
See all related articles

A new multipoint microbiological assay accurately detects beta-lactamase production in key bacteria. This inexpensive and reliable method aids conventional antibiotic susceptibility testing.

Area of Science:

  • Microbiology
  • Clinical Diagnostics
  • Bacteriology

Background:

  • Beta-lactamase enzymes confer bacterial resistance to beta-lactam antibiotics.
  • Accurate detection of beta-lactamase production is crucial for effective antimicrobial therapy.
  • Clinical isolates frequently exhibit beta-lactamase activity, necessitating reliable diagnostic methods.

Purpose of the Study:

  • To evaluate a novel multipoint microbiological assay for detecting beta-lactamase production.
  • To assess the assay's performance against a established reference method.
  • To determine the utility of the multipoint assay in routine clinical microbiology.

Main Methods:

  • A multipoint microbiological assay was developed and utilized.
  • Bacterial strains including *Haemophilus influenzae*, *Neisseria gonorrhoeae*, and *Branhamella catarrhalis* were tested.

Related Experiment Videos

  • Results were compared against a chromogenic cephalosporin reference method.

    • Main Results:

    • The multipoint assay demonstrated excellent correlation with the chromogenic cephalosporin reference method.
    • High accuracy was observed for detecting beta-lactamase production in the tested bacterial species.
    • The method proved reliable for clinical isolates.

    Conclusions:

    • The multipoint microbiological assay is a dependable tool for identifying beta-lactamase production.
    • This assay serves as a cost-effective adjunct to standard antibiotic susceptibility testing.
    • The method offers a reliable alternative for routine clinical laboratories.